About Bios Partners
Bios Partners is a Financial Services company based in Fort Worth (United States) founded in 2017. Venture capital is provided by Bios Partners for biotech innovation. It operates on a Commission-Based model. Bios Partners offers products and services including Venture Capital Investment. Its focus areas include Finance, Venture Capital and Biotechnology Investment.
Company details
Bios Partners is engaged in providing venture capital to advanced biotech companies located in overlooked and under-invested markets across the Central United States. The firm focuses on disrupting geographic favoritism in venture capital by investing in compelling scientific opportunities that are often undervalued. Support is extended to cultivate and bring innovative solutions to market, particularly in sectors like pharmaceuticals, medical devices, cell therapy, digital medicines, and AI-driven therapeutics. Their portfolio includes clinical-stage companies addressing high-impact cancers, neurodegenerative disorders, rare genetic diseases, and vision loss.
- Headquarters Fort Worth, United States
- SectorsFinancial Services
- Email••••••••
- Phone•••• ••••
- Website biospartners.com
Products & Services of Bios Partners
Bios Partners offers a comprehensive portfolio of products and services, including Venture Capital Investment.
Venture capital is provided for biotech innovation development.
People of Bios Partners
12 people are tracked at Bios Partners (10 in leadership, 2 in team).
| Name | Role | Group |
|---|---|---|
Leslie W. Kreis, Jr. | Managing Partner & Co-Founder | Leadership |
Daniel Schwarz | COO & CFO | Leadership |
Troy Osborn | Chief Financial Officer | Leadership |
Stella M. Robertson | Co-Founder & Partner | Leadership |
Aaron G.L. Fletcher | Managing Partner & Co-Founder | Leadership |
Blake Pate | Vice President, Investments | Leadership |
Stephen Phillips | Vice President | Leadership |
Les Kreis | Co Managing Partner | Leadership |
John Fucci | Partner | Leadership |
Amanda De La Garza | Partner | Leadership |
Roni Meintjes | Analyst | Team |
Tim Van Treuren | Analyst | Team |
Complete people profiles for Bios Partners
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Top companies in Venture Capital Funds
3 companies that operate in the same segment as Bios Partners (Venture Capital Funds) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Venture capital firm investing in early-stage tech startups | 1972 | Menlo Park, California, United States | ||||
Venture capital investments and support for entrepreneurs in technology and innovation sectors. | 1911 | Redwood City, California, United States | USD 691.23 K | |||
Accel is recognized as a leading venture capital firm. | 1983 | Palo Alto, California, United States |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Bios Partners
Bios Partners was founded in 2017.
Bios Partners is headquartered in Fort Worth, United States. It is registered at Fort Worth, Texas, United States.
Bios Partners is engaged in providing venture capital to advanced biotech companies located in overlooked and under-invested markets across the Central United States. The firm focuses on disrupting geographic favoritism in venture capital by investing in compelling scientific opportunities that are often undervalued. Support is extended to cultivate and bring innovative solutions to market, particularly in sectors like pharmaceuticals, medical devices, cell therapy, digital medicines, and AI-driven therapeutics. Their portfolio includes clinical-stage companies addressing high-impact cancers, neurodegenerative disorders, rare genetic diseases, and vision loss.
Bios Partners offers Venture Capital Investment.